[Event Report] Sixth Meeting of the “Rebalancing Healthcare Systems: Innovation and Sustainability” Taskforce: Value Based Medicine – Philosophy and Methods (March 16, 2020)
date : 4/2/2020
Tags: Future of the Health Care System, Innovation and Sustainability
![[Event Report] Sixth Meeting of the “Rebalancing Healthcare Systems: Innovation and Sustainability” Taskforce: Value Based Medicine – Philosophy and Methods (March 16, 2020)](https://hgpi.org/en/wp-content/uploads/sites/2/P3160164_r.jpg)
HGPI held the sixth meeting of the “Rebalancing Healthcare Systems: Innovation and Sustainability” Taskforce on the topic of the “Value Based Medicine – Philosophy and Methods.”
Since the achievement of universal health coverage in 1961, the Japanese health system has supported the growth of the one of the healthiest and longest living populations in the world. As that population continues to age, Japan is being presented with a tremendous opportunity: to show the rest of the world how a super-aging society can successfully maintain a national health insurance system that works for all generations, and that can incorporate medical innovations and ensure healthy longevity even under circumstances in which members of the population regularly live to over 100-years of age.
As part of its “Rebalancing Healthcare Systems: Innovation and Sustainability” project, HPGI has formed a taskforce to debate policy measures that can support the achievement of such a system. This taskforce aims to produce an expert report on the health policy opportunities available to Japan within FY2020.
At this sixth fourth taskforce meeting, taskforce members discussed how the concepts of value based medicine can be reflected in health systems and the significance of evaluating value from various perspectives.
In light of the situation with novel coronavirus, this meeting was carried out primarily online. On-site participants were encouraged to keep a safe physical distance from each other.
■Overview
Date and time: Monday, March 16, 2020
Organizer: HGPI
■Program
Presentation “Value Based Medicine – Philosophy and Methods”
Ataru Igarashi (Associate Professor, Unit of Public Health and Preventive Medicine, Yokohama City University of Medicine / Visiting Associate Professor, Graduate School of Pharmaceutical Sciences, The University of Tokyo / Fellow, HGPI)
Taskforce Discussion
Taskforce Members (alphabetical order by last name):
Akihisa Harada (President, Pfizer Japan Inc.)
Mamoru Ichikawa (Principal Program Director, Production Center 3 Science Programs Division, Japan Broadcasting Corporation (NHK))
Satoshi Imamura (Vice-President, Japan Medical Association)
Kyoko Miyahara (Corporate Affairs, Health & Value Lead, Pfizer Japan Inc.)
Toshio Nagase (Senior Director, Government Affairs Japan, Gilead Science K.K.)
Hiroshi Nakamura (Professor, Graduate School of Business Administration, Keio University)
Kazumasa Oguro (Professor, Faculty of Economics, Hosei University)
Naokazu Saito (Director, Policy Intelligence Department, Janssen Pharmaceutical K.K.)
Naomi Sakurai (President, Cancer Solutions Co., Ltd.)
Eiko Shimizu (Project Associate Professor, ITHC, Graduate School of Pharmaceutical Sciences, The University of Tokyo)
Mitsuo Umezu (Director, Institute for Medical Regulatory Science, Waseda University)
Hirokazu Yoshii (Special Advisor to the President, Health Insurance Claims Review & Reimbursement Services)
Observer:
Michinori Haba (Director for Budget, Budget Bureau, Ministry of Economy, Trade and Industry of Japan (METI))
Moderators:
Ataru Igarashi (Associate Professor, Unit of Public Health and Preventive Medicine, Yokohama City University of Medicine / Visiting Associate Professor, Graduate School of Pharmaceutical Sciences, The University of Tokyo / Fellow, HGPI)
Joji Sugawara (Senior Associate, HGPI)
■Related events held as part of the “Rebalancing Healthcare Systems: Innovation and Sustainability” project in FY2019 (chronological order)
October 16, 2019 First Meeting of the “Rebalancing Healthcare Systems: Innovation and Sustainability” Taskforce: Measures to Increase Spending Efficiency
December 12, 2019 Third Meeting of the “Rebalancing Healthcare Systems: Innovation and Sustainability” Taskforce: The Further Development of Push and Pull Incentives for Innovation
Top Research & Recommendations Posts
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Strengthening Lifelong Mental Health Support for Children with Intellectual Disabilities (April 30, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
- [Event Report] Round Table Discussion “Understanding Menopausal Women’s Health as a Social Issue” (Preliminary Version) (November 19, 2024)
- [Recommendations] HGPI Expert Policy Advocacy Platform “Better Use of Cost-effectiveness Evaluation for Pharmaceuticals in Japan” (May 7, 2025)
Featured Posts
-
2025-04-17
[Registration Open] (Webinar) The 134th HGPI Seminar “Understanding Evidence-Based Dietary Guidelines: Leveraging the Dietary Reference Intakes for Japanese” (May 28, 2025)
-
2025-04-23
[Registration Open] Recruitment of the Health Policy Academy the 14th Session (Starts July 2025)
-
2025-05-02
[Registration Open] (Webinar) The 133rd HGPI Seminar -HGPI Expert Policy Advocacy Platform- “Better Use of Cost-effectiveness Evaluation for Pharmaceuticals in Japan” (May 20, 2025)
-
2025-05-07
[Recommendations] HGPI Expert Policy Advocacy Platform “Better Use of Cost-effectiveness Evaluation for Pharmaceuticals in Japan” (May 7, 2025)
-
2025-05-07
[Registration Open] Japan-Australia Online Round Table Discussion “The Impact of Social Media on the Mental Health of Children and Young People and How Social Media Should Be Used in Society“ (May 23, 2025)